QTREX Quantum (NASDAQ:QTEX) Stock Breaks Above Fifty Day Moving Average – Should You Sell?

QTREX Quantum Ltd. (NASDAQ:QTEX)’s stock price crossed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $1.13 and traded as high as $1.1950. QTREX Quantum shares last traded at $1.19, with a volume of 6,584,214 shares traded.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of QTREX Quantum from a “hold” rating to a “sell” rating in a research note on Saturday, August 8th. Weiss Ratings lowered shares of QTREX Quantum from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, October 9th. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock presently has an average rating of “Sell”.

QTREX Quantum Price Performance

The company has a debt-to-equity ratio of 0.12, a current ratio of 2.00 and a quick ratio of 1.62. The business’s 50-day moving average price is $1.13.

QTREX Quantum (NASDAQ:QTEX) last announced its quarterly earnings results on Thursday, September 24th. The company reported ($0.07) EPS for the quarter. The business had revenue of $0.78 million for the quarter.

Insider Activity

In related news, CEO Dagi Ben-Noon purchased 168,894 shares of the firm’s stock in a transaction that occurred on Monday, September 28th. The stock was acquired at an average price of $0.71 per share, for a total transaction of $119,914.74. Following the completion of the acquisition, the chief executive officer owned 3,646,133 shares of the company’s stock, valued at $2,588,754.43. This represents a 4.86% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders purchased a total of 207,834 shares of company stock worth $181,275 over the last 90 days. 29.40% of the stock is owned by insiders.

QTREX Quantum Company Profile

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support. Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.